Characteristics |
|
COVID-19 Asthma+ |
COVID-19 Asthma- |
COVID-19 Asthma+ |
COVID-19 Asthma- |
total N |
|
100 |
505 |
498 |
4493 |
Age |
|
|
|
|
|
Median (IQR) — yr |
|
53.8 [31.1 - 69.9] |
50.5 [33.3
- 67.7] |
36.5 [20.7 - 56.4] |
36.9 [24.8 -
51.8] |
Distribution — No./total no.(%) |
0-14 yr |
7.0 (7.0%) |
29.0 (5.7%) |
71.0 (14.3%) |
441.0 (9.8%) |
|
15-49 yr |
38.0 (38.0%) |
219.0 (43.4%) |
262.0 (52.6%) |
2800.0 (62.3%) |
|
50-64 yr |
21.0 (21.0%) |
116.0 (23.0%) |
101.0 (20.3%) |
800.0
(17.8%) |
|
≥65 yr |
34.0 (34.0%) |
141.0 (27.9%) |
64.0 (12.9%) |
452.0
(10.1%) |
Sex |
|
|
|
|
|
No./total no.(%) |
Female |
58 (58.0%) |
258 (51.1%) |
296
(59.4%) |
2336 (52.0%) |
|
Male |
42 (42.0%) |
247 (48.9%) |
202 (40.6%) |
2144
(47.7%) |
Race and Ethnicity |
total data available |
100 |
495 |
460 |
3493 |
No./total no.(%) |
Asian |
9 (9.0%) |
52 (10.5%) |
35
(7.6%) |
290 (8.3%) |
|
Hispanic/Latino |
49 (49.0%) |
273 (55.2%) |
205 (44.6%) |
1861 (53.3%) |
|
Non-Hispanic Black |
3 (3.0%) |
18 (3.6%) |
37 (8.0%) |
123 (3.5%) |
|
Non-Hispanic White |
25 (25.0%) |
97 (19.6%) |
138
(30.0%) |
856 (24.5%) |
|
Other |
14 (14.0%) |
55 (11.1%) |
45 (9.8%) |
363
(10.4%) |
Smoking history |
total data available |
88 |
380 |
384 |
2045 |
No./total no.(%) |
Current Smoker |
3 (3.4%) |
22 (5.8%) |
19 (4.9%) |
79 (3.9%) |
|
Former Smoker |
20 (22.7%) |
90 (23.7%) |
62 (16.1%) |
288
(14.1%) |
|
Never Smoker |
64 (72.7%) |
266 (70.0%) |
301 (78.4%) |
1662
(81.3%) |
|
Passive Smoke Exposure |
1 (1.1%) |
2 (0.5%) |
2 (0.5%) |
16
(0.8%) |
BMI classification |
total data available |
93 |
451 |
445 |
2459 |
No./total no.(%) |
Median (IQR) — BMI |
29 [25.2 -
35.3] |
27.8 [23.4 - 33.5] |
28.2 [23.9 - 34.3] |
27 [23 -
31.8] |
|
Underweight (< 18.5) |
7 (7.5%) |
29 (6.4%) |
33 (7.4%) |
183 (7.4%) |
|
Healthy Weight (18.5-24.9) |
15 (16.1%) |
125 (27.7%) |
102
(22.9%) |
698 (28.4%) |
|
Overweight (25-29.9) |
32 (34.4%) |
122 (27.1%) |
126 (28.3%) |
745 (30.3%) |
|
Obese (30-34.9) |
14 (15.1%) |
88 (19.5%) |
88 (19.8%) |
462
(18.8%) |
|
Severely Obese (35-39.9) |
12 (12.9%) |
50 (11.1%) |
42 (9.4%) |
198 (8.1%) |
|
Morbidly Obese (>=40) |
13 (14.0%) |
37 (8.2%) |
54
(12.1%) |
173 (7.0%) |
Coexisting disorder |
|
|
|
|
|
No./total no.(%) |
Any |
85 (85.0%) |
363 (71.9%) |
262
(52.6%) |
1147 (25.5%) |
|
Chronic obstructive pulmonary disease |
14 (14.0%) |
24 (4.8%) |
18 (3.6%) |
32 (0.7%) |
|
Cancer |
23 (23.0%) |
73 (14.5%) |
40 (8.0%) |
214
(4.8%) |
|
Cerebrovascular disease |
13 (13.0%) |
61 (12.1%) |
18 (3.6%) |
105 (2.3%) |
|
Chronic renal disease |
29 (29.0%) |
90 (17.8%) |
28 (5.6%) |
114
(2.5%) |
|
Coronary heart disease |
28 (28.0%) |
114 (22.6%) |
41 (8.2%) |
145 (3.2%) |
|
Diabetes |
38 (38.0%) |
178 (35.2%) |
69 (13.9%) |
324
(7.2%) |
|
Other Endocrine system disease |
15 (15.0%) |
40 (7.9%) |
37
(7.4%) |
118 (2.6%) |
|
Hypertension |
58 (58.0%) |
238 (47.1%) |
150 (30.1%) |
575
(12.8%) |
|
Immunodeficiency |
9 (9.0%) |
33 (6.5%) |
11 (2.2%) |
49
(1.1%) |
|
Liver disease |
22 (22.0%) |
83 (16.4%) |
44 (8.8%) |
224
(5.0%) |
|
Obesity |
42 (42.0%) |
131 (25.9%) |
132 (26.5%) |
370
(8.2%) |
|
Other chronic lung disease |
20 (20.0%) |
38 (7.5%) |
29 (5.8%) |
54 (1.2%) |
|
Numbers of coexisting disorder above |
3 [1 - 5] |
2 [0 - 4] |
1 [0 - 2] |
0 [0 - 1] |